These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4367406)

  • 1. Cholinergic suppression of tardive dyskinesia.
    Fann WE; Lake CR; Gerber CJ; McKenzie GM
    Psychopharmacologia; 1974 Jun; 37(4):101-7. PubMed ID: 4367406
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of cholinergic and anticholinergic agents on tardive dyskinesia.
    Klawans HL; Rubovits R
    J Neurol Neurosurg Psychiatry; 1974 Aug; 37(8):941-7. PubMed ID: 4418481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid after treatment with probenecid in patients with drug-induced tardive dyskinesia.
    Pind K; Faurbye A
    Acta Psychiatr Scand; 1970; 46(4):323-6. PubMed ID: 4323062
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis.
    Davis KL; Berger PA
    Biol Psychiatry; 1978 Feb; 13(1):23-49. PubMed ID: 146524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the action of certain pharmacological agents on tardive dyskinesia and on the rabbit syndrome.
    Jus K; Jus A; Gautier J; Villeneuve A; Pires P; Pineau R; Villeneuv R
    Int J Clin Pharmacol; 1974 Mar; 9(2):138-45. PubMed ID: 4827556
    [No Abstract]   [Full Text] [Related]  

  • 6. Lithium carbonate in the treatment of tardive dyskinesia.
    Reda FA; Escobar JI; Scanlan JM
    Am J Psychiatry; 1975 May; 132(5):560-2. PubMed ID: 804260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical observations of the treatment of tardive dyskinesia with haloperidol.
    Frangos E; Christodoulides H
    Acta Psychiatr Belg; 1975 Jan; 75(1):19-32. PubMed ID: 785948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tardive dyskinesia in schizophrenic patients treated with psychotropic drugs.
    Crane GE
    Agressologie; 1968; 9(2):209-18. PubMed ID: 5675488
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
    Kamianov IM; Kupisk AG; Katsen IZ
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(8):1218-23. PubMed ID: 4149581
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholinergic influences in tardive dyskinesia.
    Tamminga CA; Smith RC; Ericksen SE; Chang S; Davis JM
    Am J Psychiatry; 1977 Jul; 134(7):769-74. PubMed ID: 869054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudoparkinsonism and tardive dyskinesia.
    Crane GE
    Arch Neurol; 1972 Nov; 27(5):426-30. PubMed ID: 5078897
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: Deanol in tardive dyskinesia.
    Tarsy D
    N Engl J Med; 1974 Dec; 291(26):1416. PubMed ID: 4427649
    [No Abstract]   [Full Text] [Related]  

  • 13. Persistent dyskinesia.
    Crane GE
    Br J Psychiatry; 1973 Apr; 122(569):395-405. PubMed ID: 4577946
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of tardive dyskinesia. 3. Clinical efficacy of a dopamine competing agent, methyldopa.
    Kazamatsuri H; Cole JO
    Arch Gen Psychiatry; 1972 Dec; 27(6):824-7. PubMed ID: 4637899
    [No Abstract]   [Full Text] [Related]  

  • 15. Physostigmine in tardive dyskinesia.
    Carman JS
    Lancet; 1972 Dec; 2(7792):1424-5. PubMed ID: 4118718
    [No Abstract]   [Full Text] [Related]  

  • 16. Tardive dyskinesia: its relation to neuroleptic and antiparkinson drugs.
    Turek I; Kurland AA; Hanlon TE; Bohm M
    Br J Psychiatry; 1972 Dec; 121(565):605-12. PubMed ID: 4648433
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia.
    Gerlach J; Reisby N; Randrup A
    Psychopharmacologia; 1974 Jan; 34(1):21-35. PubMed ID: 4593518
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiology of tardive dyskinesia. Part II.
    Jus A; Pineau R; Lachance R; Pelchat G; Jus K; Pires P; Villeneuve R
    Dis Nerv Syst; 1976 May; 37(5):257-61. PubMed ID: 1261344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deanol in tardive dyskinesia.
    De Silva L; Huang CY
    Br Med J; 1975 Aug; 3(5981):466. PubMed ID: 1156821
    [No Abstract]   [Full Text] [Related]  

  • 20. [The semiology of motor function disorders during treatment with neuroleptic drugs].
    Fleĭs EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(12):1798-804. PubMed ID: 5511943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.